Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EAGLES: Varenicline and Bupropion for Smoking Cessation
NCT01456936Phase 4Completed
- Sponsor
- Pfizer
- Start
- Nov 2011
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 4 trial of varenicline, bupropion in nicotine dependence, sponsored by Pfizer. Started Nov 2011; status: completed.
02
Drugs
vareniclinebupropion
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01456936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01456936.